{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:27:39Z","timestamp":1794137259385,"version":"4.8.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Passively-acquired respiratory syncytial virus (RSV) neutralizing antibody (Ab) can protect against RSV-associated lower respiratory tract illness. Maternal RSV immunization is, therefore, an attractive strategy for protection of very young infants. Vaccines for this purpose are currently being evaluated in clinical trials, but conditions such as preterm birth, placental malaria, maternal hypergammaglobulinemia and HIV infection might threaten this strategy. Each has been shown to impair transplacental Ab transfer for a variety of pathogens, but RSV-specific data are limited. Work in The Gambia demonstrated that placental malaria impaired transplacental transfer of RSV Ab, but a subsequent study in malaria-endemic Papua New Guinea (PNG) indicated that such associations may have been confounded by hypergammaglobulinemia (IgG &gt; 1700\u2009mg\/dL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Here we confirm and extend those findings by measuring RSV neutralizing Ab and maternal IgG in sera from a larger cohort of 325 mother\/infant pairs in PNG, and demonstrate the applicability of a high-throughput assay for assessment of neutralizing Ab.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One-third of mother-infant pairs demonstrated impaired RSV Ab transfer. Infants of hypergammaglobulinemic women were more likely to have both impaired transfer [cord-to-maternal titer ratio &lt;1.0, adjusted odds ratio (OR): 3.36 (95% confidence interval: 1.81\u20136.30)] and the lowest RSV cord titers [adjusted OR: 5.09 (95% confidence interval: 1.95\u201313.32, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001)], but neither outcome was associated with placental malaria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Once maternal RSV vaccines become available, successful implementation will require clear understanding and mitigation of factors that can impair passive protection, necessitating epidemiologic studies of such relationships ahead of vaccine availability. This study underscores the need to focus on hypergammaglobulinemia as a condition of importance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002364","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:37:15Z","timestamp":1565710635000},"page":"e199-e202","source":"Crossref","is-referenced-by-count":17,"title":["Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea"],"prefix":"10.1097","volume":"38","author":[{"given":"Jessica E.","family":"Atwell","sequence":"first","affiliation":[{"name":"Department of International, Center for Immunization Research, Health Johns Hopkins School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagvanji","family":"Thumar","sequence":"additional","affiliation":[{"name":"Department of International, Center for Immunization Research, Health Johns Hopkins School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Formica","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rochester General Hospital, University of Rochester, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne J.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rochester General Hospital, University of Rochester, New York, New York"},{"name":"Burnet Institute, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward E.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rochester General Hospital, University of Rochester, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[{"name":"Center for Global Health and Disease, Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Karron","sequence":"additional","affiliation":[{"name":"Department of International, Center for Immunization Research, Health Johns Hopkins School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/INF.0b013e31815ac585","article-title":"The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.","volume":"27","author":"Eick","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jiv401","article-title":"Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea.","volume":"213","author":"Atwell","year":"2016","journal-title":"J Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/322808","article-title":"The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population.","volume":"184","author":"Okoko","year":"2001","journal-title":"J Infect Dis"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12916-014-0258-3","article-title":"Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial.","volume":"13","author":"Unger","year":"2015","journal-title":"BMC Med"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.","volume":"210","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies.","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2008.07.053","article-title":"Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.","volume":"154","author":"Stensballe","year":"2009","journal-title":"J Pediatr"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.vaccine.2015.02.039","article-title":"Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.","volume":"33","author":"Nyiro","year":"2015","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:53:53Z","timestamp":1694559233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002364","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}